These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 1899400)

  • 1. Gonadotropin-releasing hormone agonist (leuprolide acetate) induced ovarian hyperstimulation syndrome in a woman undergoing intermittent hemodialysis.
    Hampton HL; Whitworth NS; Cowan BD
    Fertil Steril; 1991 Feb; 55(2):429-31. PubMed ID: 1899400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful management of predicted severe ovarian hyperstimulation syndrome with gonadotropin-releasing hormone agonist.
    Wu TC; Gelety TJ; Jih MH; Fournet N; Buyalos R
    J Assist Reprod Genet; 1992 Jun; 9(3):281-3. PubMed ID: 1525462
    [No Abstract]   [Full Text] [Related]  

  • 3. Gonadotropin-releasing hormone agonist-induced ovarian hyperstimulation: low-dose side effects in women and monkeys.
    Navot D; Rosenwaks Z; Anderson F; Hodgen GD
    Fertil Steril; 1991 Jun; 55(6):1069-75. PubMed ID: 1828042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gonadotropin-releasing hormone antagonist versus agonist administration in women undergoing controlled ovarian hyperstimulation: cycle performance and in vitro steroidogenesis of granulosa-lutein cells.
    Minaretzis D; Alper MM; Oskowitz SP; Lobel SM; Mortola JF; Pavlou SN
    Am J Obstet Gynecol; 1995 May; 172(5):1518-25. PubMed ID: 7755066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of ovarian hyperstimulation syndrome.
    Amso NN; Shaw RW; Ahuja KK; Morris N
    Fertil Steril; 1991 Jan; 55(1):220-1. PubMed ID: 1986965
    [No Abstract]   [Full Text] [Related]  

  • 6. An alternate approach to controlled ovarian hyperstimulation in "poor responders": pretreatment with a gonadotropin-releasing hormone analog.
    Serafini P; Stone B; Kerin J; Batzofin J; Quinn P; Marrs RP
    Fertil Steril; 1988 Jan; 49(1):90-5. PubMed ID: 3121401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term administration of gonadotropin-releasing hormone agonist and dexamethasone: assessment of the adrenal role in ovarian dysfunction.
    Cedars MI; Steingold KA; de Ziegler D; Lapolt PS; Chang RJ; Judd HL
    Fertil Steril; 1992 Mar; 57(3):495-500. PubMed ID: 1531463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leuprolide acetate elevates prolactin during ovarian stimulation with gonadotropins.
    Meldrum DR; Cedars MI; Hamilton F; Huynh D; Wisot A; Marr B
    J Assist Reprod Genet; 1992 Jun; 9(3):251-3. PubMed ID: 1525456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations in luteal phase progesterone and estradiol production after leuprolide acetate therapy before ovarian stimulation for in vitro fertilization.
    Brzyski RG; Jones GS; Jones HW; Oehninger S; Muasher SJ
    Fertil Steril; 1991 Jan; 55(1):119-24. PubMed ID: 1898886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gonadotropin-releasing hormone agonists induce meiotic maturation and degeneration of oocytes in the in vitro perfused rabbit ovary.
    Yoshimura Y; Nakamura Y; Yamada H; Nanno T; Ubukata Y; Ando M; Suzuki M
    Fertil Steril; 1991 Jan; 55(1):177-83. PubMed ID: 1898889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ovarian hyporesponsiveness in combined gonadotropin-releasing hormone agonist and menotropin therapy is associated with low serum follicle-stimulating hormone levels.
    Ben-Rafael Z; Lipitz S; Bider D; Mashiach S
    Fertil Steril; 1991 Feb; 55(2):272-5. PubMed ID: 1825069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparable clinical outcome using the GnRH antagonist ganirelix or a long protocol of the GnRH agonist triptorelin for the prevention of premature LH surges in women undergoing ovarian stimulation.
    European and Middle East Orgalutran Study Group
    Hum Reprod; 2001 Apr; 16(4):644-51. PubMed ID: 11278211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamics of plasma gonadotropin and sex steroid release in polycystic ovarian disease after pituitary-ovarian inhibition with an analog of gonadotropin-releasing hormone.
    Calogero AE; Macchi M; Montanini V; Mongioi A; Maugeri G; Vicari E; Coniglione F; Sipione C; D'Agata R
    J Clin Endocrinol Metab; 1987 May; 64(5):980-5. PubMed ID: 3104389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjunctive leuprolide therapy does not improve cycle fecundity in controlled ovarian hyperstimulation and intrauterine insemination of subfertile women.
    Dodson WC; Walmer DK; Hughes CL; Yancy SE; Haney AF
    Obstet Gynecol; 1991 Aug; 78(2):187-90. PubMed ID: 1906152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Response to D-Trp-6-luteinising hormone releasing hormone (Decapeptyl) microcapsules in advanced ovarian cancer.
    Parmar H; Rustin G; Lightman SL; Phillips RH; Hanham IW; Schally AV
    Br Med J (Clin Res Ed); 1988 Apr; 296(6631):1229. PubMed ID: 2968130
    [No Abstract]   [Full Text] [Related]  

  • 16. Use of a single bolus of GnRH agonist triptorelin to trigger ovulation after GnRH antagonist ganirelix treatment in women undergoing ovarian stimulation for assisted reproduction, with special reference to the prevention of ovarian hyperstimulation syndrome: preliminary report: short communication.
    Itskovitz-Eldor J; Kol S; Mannaerts B
    Hum Reprod; 2000 Sep; 15(9):1965-8. PubMed ID: 10966996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of human menopausal gonadotropin and follicle-stimulating hormone with gonadotropin-releasing hormone agonist desensitization for controlled ovarian hyperstimulation in in vitro fertilization.
    Yang TS; Wang BC; Chang SP; Ng HT
    Zhonghua Yi Xue Za Zhi (Taipei); 1995 Jun; 55(6):452-6. PubMed ID: 7634183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A pilot study of the use of gonadotropin-releasing hormone analog for triggering ovulation.
    Tulchinsky D; Nash H; Brown K; Paoletti-Falcone V; Polcaro J
    Fertil Steril; 1991 Mar; 55(3):644-6. PubMed ID: 1900489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Empty follicle syndrome in perimenopausal patients.
    Greb R; van Uem JF; Bauer T
    Fertil Steril; 1993 May; 59(5):1141-2. PubMed ID: 8486189
    [No Abstract]   [Full Text] [Related]  

  • 20. Performance of cryopreserved pre-embryos obtained in in vitro fertilization cycles with or without a gonadotropin-releasing hormone agonist.
    Oehninger S; Toner JP; Veeck LL; Brzyski RG; Acosta AA; Muasher SJ
    Fertil Steril; 1992 Mar; 57(3):620-5. PubMed ID: 1740208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.